Home » Business » Osunkeye out, Onuzo in at GlaxoSmithKline
Osunkeye out, Onuzo in at GlaxoSmithKline

Osunkeye out, Onuzo in at GlaxoSmithKline

GlaxoSmithKline Nigeria Plc has announced the resignation and retirement of Chief Olusegun Osunkeye as Chairman from the Board of the Company and thanked him for his immense contributions throughout his stay.
In a letter to notify the Nigeria Stock Exchange of this development following a Board Meeting, it also revealed that it has accepted the resignation from the Board of Engr. Mansur Ahmed and Mr. Madike Seye with effect June 12, 2014.

Furthermore, it announced the election of a non-executive directors, Mr. Edmund Onuzo as the new Chairman of the Company effective June 12, 2014. That was not all,  Mr. Olalekan Asuni and Mr. Samuel Kuye were also appointed as non-executive directors. 

Mr. Samuel Olawale Kuye: is a Chartered Accountant and a fellow of the Institute of Chartered Accounts of Nigeria (FCA).

Born in Ijebu-Ode, Ogun State Nigeria, Mr. Kuye started his career in Nestle Nigeria in 1974 and over the years, has held various positions in Finance and Control as well as management of the company’s Pension Fund. In 2000, He returned from Switzerland to Nigeria as the Finance & Control Director and Chief Financial Officer of the Company a position he held until 2004 when he was transferred to Egypt. Prior to his assignment in Switzerland, he was the Assistant Group Controller of the Nestle Group for Southern African Region from 1995 to 1996.

From 1998 to 2000, Mr Kuye worked at the Nestle Group’s headquarters in Switzerland as Controller, responsible for 6 countries in Asia (Philippines, Malaysia, Thailand, Indonesia, Vietnam and Singapore). In 2004, he moved to Egypt as the Finance & Control Director and Chief Financial Officer of the Group for North East African Region. He moved to Turkey in 2007.
After 36 years with the Nestle Group, Mr. Kuye retired as Finance & Controller Director and Chief Financial Officer of the Company for Turkey at the end of October 2010.

He is an independent member of Stanbic IBTC Bank Mutual Funds Investment Committee and has attended various Senior Management courses at the Nestle Management Training Centre, Vevey Switzerland and the London Business School, London UK.

He is currently the Chief Executive of a Management and Financial Consultancy Organisation, SEOOM Limited upon this appointment.

Mr. Olalekan Asuni: holds a Bachelor of Pharmacy degree from Obafemi Awolowo University, Ile-Ife, Nigeria and a Masters of Business Administration (MBA). He is also an Alumnus of Ashridge Business School, UK.

He started his professional career with Gastro/OTC in 1991 as a Medical Representative rising to a Senior Medical Representative between 1996 – 1999, he became the Product Manager and rose to become the Group Product Manager of the Company (Jan. 2000 – November 2004).

Lekan joined the GlaxoSmithKline Pharmaceutical Anglophone and Central Africa in November 2004 as Marketing and HSA Manager while from April 2006 – June 2008, he became the Marketing Director charged with the responsibility of formulating and directing the company’s marketing strategy in Anglophone West and Central Africa among other responsibilities. On July 1, 2008, he became the Managing Director of the Company.

Mr. Asuni recorded numerous achievements in the course of his career among which are leading the team that produced the Best Strategy at Building Great Brand I & II workshop, led the GSK Pharmaceutical Nigeria local manufacturing capacity building project among others.
He has attended several general management and function-specific workshops and courses locally and internationally. He is presently the Managing Director, GlaxoSmithKline Pharmaceutical West Africa prior to this appointment.

Leave a Reply

Your email address will not be published.

%d bloggers like this: